Treatment of epilepsy in adults
159 results
1 - 100
Treatment of epilepsy in adults 
Immunomodulatory interventions for focal epilepsy- Cenobamate add‐on therapy for drug‐resistant focal epilepsy
- Oxcarbazepine add-on for drug-resistant partial epilepsy: Cochrane systematic review
- Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
- Brivaracetam add‐on therapy for drug‐resistant epilepsy
- Clonazepam add‐on therapy for drug‐resistant epilepsy
- Levetiracetam add‐on for drug‐resistant focal epilepsy
- Psychological treatments for people with epilepsy
- Acupuncture for epilepsy
- Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
- Treatment of a prolonged epileptic seizure and status epilepticus
- Strategies for improving adherence to antiepileptic drug treatment in epilepsy
- Neuropsychological and psychological interventions for people with newly diagnosed epilepsy
- Pregabalin add‐on for drug‐resistant focal epilepsy
- Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
- Carbamazepine versus valproate monotherapy for epilepsy
- Clinical neurophysiology in diagnostics
- Topiramate add‐on therapy for drug‐resistant focal epilepsy
- Lacosamide add‐on therapy for focal epilepsy
- Levetiracetam for partial epilepsy in adults
- Melatonin as add‐on treatment for epilepsy
- Epilepsy in children
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review: Cochrane systematic review
- Rufinamide add‐on therapy for refractory epilepsy
- Carisbamate add‐on therapy for drug‐resistant focal epilepsy
- Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
- Brivaracetam add‐on therapy for drug‐resistant epilepsy
- Care delivery and self‐management strategies for children with epilepsy
- Yoga for epilepsy
- Early versus late antiepileptic drug withdrawal for people with epilepsy in remission: Cochrane systematic review
- Lamotrigine add-on for drug-resistant partial epilepsy
- Ketogenic diets for drug‐resistant epilepsy
- Pregabalin monotherapy for epilepsy: Cochrane systematic review
- Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Rufinamide add‐on therapy for drug‐resistant epilepsy
- Gabapentin add‐on treatment for drug‐resistant focal epilepsy
- Sequelae of traumatic brain injury
- Oxcarbazepine versus phenytoin monotherapy for epilepsy
- Gabapentin for drug resistant partial epilepsy
- Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy
- Vigabatrin versus carbamazepine monotherapy for epilepsy
- Rapid versus slow withdrawal of antiepileptic drugs
- Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- A patient with intellectual disability (ID) in a medical consultation
- Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
- Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
- Single dose oral gabapentin for established acute postoperative pain in adults
- Zonisamide for neuropathic pain in adults
- Early versus late antiepileptic drug withdrawal in pediatric epilepsy
- Lacosamide add-on therapy for partial epilepsy
- Antidepressants for people with epilepsy and depression
- Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
- Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Eslicarbazepine add-on for drug-resistant partial epilepsy
- Clobazam add‐on therapy for drug‐resistant epilepsy
- Tiagabine add‐on therapy for drug‐resistant focal epilepsy